Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05278650 · ClinicalTrials.gov registry record · NA

Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation

A NA study of Implementation Science and Medication Therapy Management, sponsored by Duke University.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT05278650: Completed NA study of Implementation Science and Medication Therapy Management, sponsored by Duke University.

NCT05278650 is a NA study of Implementation Science and Medication Therapy Management that has completed, run by Duke University. The registered enrollment target is 7 participants, below the 1,743-participant average among 13 other Implementation Science trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05278650, a NA study of Implementation Science and Medication Therapy Management, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

This project aims to evaluate the scalability of an established, evidence-based, multi-component intervention, Senior PharmAssist\^TM (SPA), designed to improve function and quality of life of older adults with limited incomes. The investigators propose to refine existing SPA replication materials such as community readiness assessments, educational tools to facilitate implementation of care processes, and data collection tools for quality improvement with input from community stakeholders interested in implementation of the SPA intervention. After gathering feedback from key stakeholders in 3 diverse communities in North Carolina, and refining tools accordingly, SPA staff will then provide technical assistance to support implementation in these communities, using the Institute for Healthcare Improvement learning collaborative approach, to facilitate community agency staff implementation of the SPA core components with racially diverse older adults with limited incomes using small scale tests of change with feedback. The investigators will collect data from key stakeholders including older adults, community volunteers, and agency staff regarding facilitators and barriers to implementation of SPA, and obtain aggregate data regarding older adult participants served, including demographics, participant satisfaction, and self-rated health. Data will be analyzed using a multiple case study design that incorporates both qualitative data on barriers and facilitators, as well as aggregated data on older adults enrolled in community programs.

Interventions

  • OTHER Senior PharmAssist^TM Program Implementation

Study Locations (1)

North Carolina

  • Duke University Health System - Durham

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2022-08-24
Est. Completion 2024-07-31
Phase NA
Duke University

1,725 total trials

What the finished NCT05278650 record still lists

NCT05278650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,743-participant average among 13 other Implementation Science trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Implementation Science appearing as the primary indexed condition, and to 1 intervention - of which Senior PharmAssist^TM Program Implementation is the first listed.

NCT05278650 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05278650 about?

NCT05278650 is a clinical study titled "Senior PharmAssist: Co-Design and Evaluation of a Toolkit to Promote Scalable Implementation". This project aims to evaluate the scalability of an established, evidence-based, multi-component intervention, Senior PharmAssist\^TM (SPA), designed to improve function and quality of life of older adults with limited incomes. The investigators propose to refine existing SPA replication materials s...

What is the current status of trial NCT05278650?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2022-08-24. Estimated completion is 2024-07-31.

What conditions does trial NCT05278650 study?

This clinical trial studies the following conditions: Implementation Science, Medication Therapy Management.

What interventions are being tested in trial NCT05278650?

The interventions under investigation include: Senior PharmAssist^TM Program Implementation (OTHER).

Who is sponsoring clinical trial NCT05278650?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05278650 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Implementation Science

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05278650's enrollment target sits among peer trials

7 14th of 13 the lowest of 13 other Implementation Science trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Implementation Science trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05278650, the US trial registry maintained by the National Library of Medicine. NCT05278650 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.